HLS Therapeutics Appoints Craig Millian CEO to Head Company

marketwatch

17 Apr 2023

By Adriano Marchese

HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chief executive officer, effective the beginning of May.

The Toronto-based pharmaceutical company, which is focused on cardiovascular and central nervous system therapeutics, said Mr. Millian's appointment coincides with current CEO Gilbert Godin's retirement on May 1, and is the result of an extensive search conducted by the company board.

Mr. Millian served as chief operating officer at Corbus Pharmaceuticals Holdings Inc., and held commercial leadership positions at EMD Serono, the Canadian biopharmaceutical business of Merck KGaA.

Write to Adriano Marchese at adriano.marchese@wsj.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2328089894"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2328089894\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2328089894?lang=en_US&edition=fundamental","thumbnail":"https://images.mktw.net/im-763164?size=1.777777777777778&width=220 220w","is_english":true,"pubTime":"2023-04-17 19:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2328089894","market":"us","top_or_hot":-1,"title":"HLS Therapeutics Appoints Craig Millian CEO to Head Company","media":"marketwatch","content":"<html><body><div itemprop=\"articleBody\" role=\"document\"> <div> <div> <div aria-hidden=\"true\"></div> </div> </div> <p>By Adriano Marchese</p><pre></pre> <p>HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chief executive officer, effective the beginning of May.</p> <p>The Toronto-based pharmaceutical company, which is focused on cardiovascular and central nervous system therapeutics, said Mr. Millian's appointment coincides with current CEO Gilbert Godin's retirement on May 1, and is the result of an extensive search conducted by the company board.</p> <div> <p>Mr. Millian served as chief operating officer at Corbus Pharmaceuticals Holdings Inc., and held commercial leadership positions at EMD Serono, the Canadian biopharmaceutical business of Merck KGaA.</p><pre></pre> <p>Write to Adriano Marchese at adriano.marchese@wsj.com</p><pre></pre> </div> </div></body></html>","source":"mwatch_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HLS Therapeutics Appoints Craig Millian CEO to Head Company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHLS Therapeutics Appoints Craig Millian CEO to Head Company\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-04-17 19:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/hls-therapeutics-appoints-craig-millian-ceo-to-head-company-62a399ea?mod=newsviewer_click><strong>marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Adriano Marchese HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chief executive officer, effective the beginning of May. The Toronto-based pharmaceutical company, ...</p>\n\n<a href=\"https://www.marketwatch.com/story/hls-therapeutics-appoints-craig-millian-ceo-to-head-company-62a399ea?mod=newsviewer_click\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.marketwatch.com/story/hls-therapeutics-appoints-craig-millian-ceo-to-head-company-62a399ea?mod=newsviewer_click","article_id":"2328089894","we_media_id":null,"thumbnails":["https://images.mktw.net/im-763164?size=1.777777777777778&width=220 220w"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2328089894","pubTimestamp":1681731660,"columns":[],"sourceInfo":{"source_id":"mwatch_stock","name":"Market Watch"},"weMediaInfo":null,"summary":"By Adriano Marchese HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chi","collect":0,"end_time":0,"defaultTopTitle":"marketwatch.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","TERN":"Terns Pharmaceuticals, Inc.","BK4191":"家用电器","CRCT":"Cricut, Inc.","BK4539":"次新股"},"translate_title":"HLS治疗任命克雷格米利安首席执行官领导公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRCT":0.83,"HLS":1,"TERN":0.83},"content_text":"By Adriano Marchese HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chief executive officer, effective the beginning of May. The Toronto-based pharmaceutical company, which is focused on cardiovascular and central nervous system therapeutics, said Mr. Millian's appointment coincides with current CEO Gilbert Godin's retirement on May 1, and is the result of an extensive search conducted by the company board.  Mr. Millian served as chief operating officer at Corbus Pharmaceuticals Holdings Inc., and held commercial leadership positions at EMD Serono, the Canadian biopharmaceutical business of Merck KGaA. Write to Adriano Marchese at adriano.marchese@wsj.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}